Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in Thailand
- Author
- KARNASUTA, Chitraporn1 ; PARIS, Robert M1 ; MCNEIL, John G2 ; BIRX, Deborah L2 ; DE SOUZA, Mark S1 ; COX, Josephine H2 ; NITAYAPHAN, Sorachai1 ; PITISUTTITHUM, Punnee3 ; THONGCHAROEN, Prasert4 ; BROWN, Arthur E1 ; GURUNATHAN, Sanjay5 ; TARTAGLIA, James6 ; HEYWARD, William L7
[1] Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
[2] U.S. Military HIV Research Programme, Rockville, MD, United States
[3] Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
[4] Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
[5] Aventis Pasteur, Swiftwater, PA, United States
[6] Aventis Pasteur, Toronto, Canada
[7] VaxGen, Brisbane, CA, United States
TAVEGThai AIDS Vaccine Evaluation Group, Thailand - Source
Vaccine. 2005, Vol 23, Num 19, pp 2522-2529, 8 p ; ref : 46 ref
- CODEN
- VACCDE
- ISSN
- 0264-410X
- Scientific domain
- Biotechnology; Immunology, immunopathology, allergology; Microbiology, infectious diseases; Virology
- Publisher
- Elsevier, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- ADCC HIV-1 Prime-boost vaccine
- Keyword (fr)
- Immunité humorale Réponse immune Vaccin Virus HIV1 Virus immunodéficience humaine Thaïlande Lentivirus Retroviridae Virus Asie
- Keyword (en)
- Humoral immunity Immune response Vaccine HIV-1 virus Human immunodeficiency virus Thailand Lentivirus Retroviridae Virus Asia
- Keyword (es)
- Inmunidad humoral Respuesta inmune Vacuna HIV-1 virus Human immunodeficiency virus Tailandia Lentivirus Retroviridae Virus Asia
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05C Virology / 002A05C10 Miscellaneous
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05F Applied microbiology / 002A05F04 Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
- Discipline
- Microbiology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17589163
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.vaccine.2004.10.028 
https://dx.doi.org/10.1016/j.vaccine.2004.10.028
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2004.10.028\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:161:\"Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I\/II ALVAC-HIV\/AIDSVAX\u00ae B\/E prime-boost HIV-1 vaccine trial in Thailand\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"19\";s:8:\"\u0000*\u0000spage\";s:4:\"2522\";s:8:\"\u0000*\u0000epage\";s:4:\"2529\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"KARNASUTA\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Chitraporn\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:15:\"PARIS, Robert M\";i:1;s:14:\"MCNEIL, John G\";i:2;s:15:\"BIRX, Deborah L\";i:3;s:16:\"DE SOUZA, Mark S\";i:4;s:16:\"COX, Josephine H\";i:5;s:20:\"NITAYAPHAN, Sorachai\";i:6;s:21:\"PITISUTTITHUM, Punnee\";i:7;s:21:\"THONGCHAROEN, Prasert\";i:8;s:15:\"BROWN, Arthur E\";i:9;s:18:\"GURUNATHAN, Sanjay\";i:10;s:16:\"TARTAGLIA, James\";i:11;s:18:\"HEYWARD, William L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:161:\"Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I\/II ALVAC-HIV\/AIDSVAX\u00ae B\/E prime-boost HIV-1 vaccine trial in Thailand\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2004.10.028\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:161:\"Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I\/II ALVAC-HIV\/AIDSVAX\u00ae B\/E prime-boost HIV-1 vaccine trial in Thailand\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"19\";s:8:\"\u0000*\u0000spage\";s:4:\"2522\";s:8:\"\u0000*\u0000epage\";s:4:\"2529\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"KARNASUTA\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Chitraporn\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:15:\"PARIS, Robert M\";i:1;s:14:\"MCNEIL, John G\";i:2;s:15:\"BIRX, Deborah L\";i:3;s:16:\"DE SOUZA, Mark S\";i:4;s:16:\"COX, Josephine H\";i:5;s:20:\"NITAYAPHAN, Sorachai\";i:6;s:21:\"PITISUTTITHUM, Punnee\";i:7;s:21:\"THONGCHAROEN, Prasert\";i:8;s:15:\"BROWN, Arthur E\";i:9;s:18:\"GURUNATHAN, Sanjay\";i:10;s:16:\"TARTAGLIA, James\";i:11;s:18:\"HEYWARD, William L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:161:\"Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I\/II ALVAC-HIV\/AIDSVAX\u00ae B\/E prime-boost HIV-1 vaccine trial in Thailand\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2004.10.028\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2004.10.028\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:161:\"Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I\/II ALVAC-HIV\/AIDSVAX\u00ae B\/E prime-boost HIV-1 vaccine trial in Thailand\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"19\";s:8:\"\u0000*\u0000spage\";s:4:\"2522\";s:8:\"\u0000*\u0000epage\";s:4:\"2529\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"KARNASUTA\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Chitraporn\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:15:\"PARIS, Robert M\";i:1;s:14:\"MCNEIL, John G\";i:2;s:15:\"BIRX, Deborah L\";i:3;s:16:\"DE SOUZA, Mark S\";i:4;s:16:\"COX, Josephine H\";i:5;s:20:\"NITAYAPHAN, Sorachai\";i:6;s:21:\"PITISUTTITHUM, Punnee\";i:7;s:21:\"THONGCHAROEN, Prasert\";i:8;s:15:\"BROWN, Arthur E\";i:9;s:18:\"GURUNATHAN, Sanjay\";i:10;s:16:\"TARTAGLIA, James\";i:11;s:18:\"HEYWARD, William L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:161:\"Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I\/II ALVAC-HIV\/AIDSVAX\u00ae B\/E prime-boost HIV-1 vaccine trial in Thailand\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2004.10.028\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:161:\"Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I\/II ALVAC-HIV\/AIDSVAX\u00ae B\/E prime-boost HIV-1 vaccine trial in Thailand\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"19\";s:8:\"\u0000*\u0000spage\";s:4:\"2522\";s:8:\"\u0000*\u0000epage\";s:4:\"2529\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"KARNASUTA\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Chitraporn\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:15:\"PARIS, Robert M\";i:1;s:14:\"MCNEIL, John G\";i:2;s:15:\"BIRX, Deborah L\";i:3;s:16:\"DE SOUZA, Mark S\";i:4;s:16:\"COX, Josephine H\";i:5;s:20:\"NITAYAPHAN, Sorachai\";i:6;s:21:\"PITISUTTITHUM, Punnee\";i:7;s:21:\"THONGCHAROEN, Prasert\";i:8;s:15:\"BROWN, Arthur E\";i:9;s:18:\"GURUNATHAN, Sanjay\";i:10;s:16:\"TARTAGLIA, James\";i:11;s:18:\"HEYWARD, William L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:161:\"Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I\/II ALVAC-HIV\/AIDSVAX\u00ae B\/E prime-boost HIV-1 vaccine trial in Thailand\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2004.10.028\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:161:\"Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I\/II ALVAC-HIV\/AIDSVAX\u00ae B\/E prime-boost HIV-1 vaccine trial in Thailand\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"19\";s:8:\"\u0000*\u0000spage\";s:4:\"2522\";s:8:\"\u0000*\u0000epage\";s:4:\"2529\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"KARNASUTA\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Chitraporn\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:15:\"PARIS, Robert M\";i:1;s:14:\"MCNEIL, John G\";i:2;s:15:\"BIRX, Deborah L\";i:3;s:16:\"DE SOUZA, Mark S\";i:4;s:16:\"COX, Josephine H\";i:5;s:20:\"NITAYAPHAN, Sorachai\";i:6;s:21:\"PITISUTTITHUM, Punnee\";i:7;s:21:\"THONGCHAROEN, Prasert\";i:8;s:15:\"BROWN, Arthur E\";i:9;s:18:\"GURUNATHAN, Sanjay\";i:10;s:16:\"TARTAGLIA, James\";i:11;s:18:\"HEYWARD, William L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:161:\"Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I\/II ALVAC-HIV\/AIDSVAX\u00ae B\/E prime-boost HIV-1 vaccine trial in Thailand\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
